Notify me when Faithward Advisors, LLC files a new 13F portfolio report.
⭐ Subscribe ⭐| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Filing Time |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 327 | $682,129,699 | +$88,065,080 | -$79,023,939 | +$9,041,141 | IBD, GLRY, IAU, PLTR, BINC | 13F-HR | 13 Feb 2026, 17:59 |
| Q3 2025 | 304 | $672,509,844 | +$107,832,922 | -$133,643,997 | -$25,811,075 | IBD, GLRY, PLTR, IAU, BINC | 13F-HR | 19 Nov 2025, 13:55 |
| Q2 2025 | 265 | $644,375,366 | +$33,024,430 | -$19,740,434 | +$13,283,996 | IBD, GLRY, ELCV, AGZ, WWJD | 13F-HR | 14 Aug 2025, 12:25 |
| Q1 2025 | 261 | $574,305,180 | +$20,313,037 | -$17,669,079 | +$2,643,958 | IBD, GLRY, ELCV, AGZ, WWJD | 13F-HR | 16 May 2025, 08:56 |
| Q4 2024 | 253 | $587,318,061 | +$71,841,378 | -$70,318,988 | +$1,522,390 | IBD, GLRY, ELCV, AGZ, WWJD | 13F-HR | 13 Feb 2025, 10:37 |
| Q3 2024 | 280 | $574,770,619 | +$48,033,400 | -$38,186,755 | +$9,846,645 | IBD, GLRY, WWJD, AGZ, BITO | 13F-HR | 14 Nov 2024, 16:51 |
| Q2 2024 | 252 | $553,029,683 | +$73,200,460 | -$57,343,313 | +$15,857,147 | IBD, GLRY, WWJD, AGZ, BITO | 13F-HR | 14 Aug 2024, 14:59 |
| Q1 2024 | 251 | $550,873,763 | +$82,004,612 | -$21,026,954 | +$60,977,658 | IBD, IBTE, GLRY, BITO, WWJD | 13F-HR | 15 May 2024, 14:40 |
| Q4 2023 | 256 | $439,501,468 | +$41,234,827 | -$38,774,012 | +$2,460,815 | IBD, IBTE, GLRY, WWJD, BITO | 13F-HR | 14 Feb 2024, 17:31 |
| Q3 2023 | 247 | $378,230,370 | +$30,658,474 | -$43,812,525 | -$13,154,051 | IBD, GLRY, WWJD, IBTE, SCHQ | 13F-HR | 14 Nov 2023, 19:58 |
| Q2 2023 | 268 | $422,921,631 | +$25,496,220 | -$49,193,918 | -$23,697,698 | SCHQ, GLRY, IBD, WWJD, BITO | 13F-HR | 14 Aug 2023, 18:36 |
| Q1 2023 | 308 | $425,944,314 | +$77,013,283 | -$123,249,686 | -$46,236,403 | IBD, GLRY, SCHQ, WWJD, IVOL | 13F-HR | 15 May 2023, 17:08 |
| Q4 2022 | 266 | $459,871,530 | +$133,653,318 | -$114,723,553 | +$18,929,765 | GLRY, IBD, SCHQ, WWJD, TPLC | 13F-HR | 14 Feb 2023, 14:26 |
| Q3 2022 | 237 | $421,867,000 | +$120,972,849 | -$118,993,526 | +$1,979,323 | IBD, TPLC, WWJD, VGSH, IVOL | Restatement | 18 Nov 2022, 09:25 |
| Q2 2022 | 258 | $445,690,000 | +$42,383,977 | -$33,507,037 | +$8,876,940 | IBD, FEVR, BIBL, GLRY, IEF | 13F-HR | 12 Aug 2022, 13:13 |
| Q1 2022 | 279 | $515,924,000 | +$33,832,698 | -$14,583,787 | +$19,248,911 | IBD, FEVR, IVOL, BIBL, GLRY | 13F-HR | 16 May 2022, 12:30 |
| Q4 2021 | 275 | $525,607,000 | +$106,024,840 | -$100,059,387 | +$5,965,453 | IBD, FEVR, BIBL, IVOL, GLRY | 13F-HR | 14 Feb 2022, 17:21 |
| Q3 2021 | 281 | $514,388,000 | +$37,727,190 | -$22,371,356 | +$15,355,834 | IBD, FEVR, IVOL, GLRY, PDBC | 13F-HR | 15 Nov 2021, 17:44 |
| Q2 2021 | 270 | $504,638,000 | +$145,125,772 | -$121,635,665 | +$23,490,107 | IBD, FEVR, IVOL, GLRY, PDBC | 13F-HR | 13 Aug 2021, 17:37 |
| Q1 2021 | 245 | $447,342,000 | +$254,217,634 | -$39,467,388 | +$214,750,246 | IBD, IEI, GLRY, IEF, FEVR | 13F-HR | 13 May 2021, 16:17 |
| Q4 2020 | 122 | $229,223,000 | +$56,156,860 | -$256,916,869 | -$200,760,009 | IBD, GLRY, FEVR, WWJD, VMBS | 13F-HR | 16 Feb 2021, 18:04 |
| Q3 2020 | 214 | $413,136,000 | +$113,338,429 | -$102,606,101 | +$10,732,328 | IEI, IBD, IEF, WWJD, TPLC | 13F-HR | 13 Nov 2020, 09:37 |
| Q2 2020 | 209 | $385,427,000 | +$113,428,010 | -$126,007,829 | -$12,579,819 | IEF, TPLC, WWJD, VMBS, SHY | 13F-HR | 13 Aug 2020, 10:49 |
| Q1 2020 | 236 | $355,088,000 | +$100,259,437 | -$101,454,526 | -$1,195,089 | IEF, TPLC, ISMD, VMBS, JPMF | 13F-HR | 11 May 2020, 21:20 |
| Q4 2019 | 240 | $425,121,000 | +$198,960,527 | -$247,787,715 | -$48,827,188 | TPLC, ISMD, IEF, TIP, RINF | 13F-HR | 22 Jan 2020, 16:40 |
| Q3 2019 | 101 | $451,781,000 | $0 | $0 | $0 | RINF, ISMD, BLES, IBD, LEMB | 13F-HR | 14 Nov 2019, 19:02 |